TG and neoplasm: Previous studies report that the success rates of the first 131I thyroid remnant ablation range from 43 to 87.2% (13–16), and some factors could possibly affect the therapeutic effectiveness, such as patient gender, surgery type, size of residual thyroid tissue, tumor size, TSH level, and thyroglobulin level (17–19).